Cancer as a Mitochondrial Metabolic Disease: Thomas Seyfried

On September 21, 2024, Professor Thomas Seyfried presented at a BSI Medical Society event in Boston. His talk focuses on cancer as a mitochondrial metabolic disease rather than a genetic one. Seyfried challenges the mainstream somatic mutation theory, which suggests that genetic mutations drive cancer. Instead, he argues that cancer arises from chronic mitochondrial damage…

Read More

Joe Rogan Guest Completely Shatters the Vaccine Narrative

Joe Rogan Guest Completely Shatters the Vaccine Narrative Everything you’ve been told is a lie—especially when it comes to polio. Dr. Suzanne Humphries, author of Dissolving Illusions, reveals what really made all those polio cases disappear after the vaccine was introduced Dr. Suzanne Humphries, former board-certified nephrologist and co-author of  Dissolving Illusions: Disease, Vaccines, and…

Read More

Ancient Chinese medicine unlocks new possibilities for cancer treatment

Ancient Chinese medicine unlocks new possibilities for cancer treatment After 20 years of research, Yale pharmacologist Yung-Chi Cheng and his partners are launching the first international clinical trial for a botanical drug. More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a…

Read More

Comparison of Blood Volume Characteristics In Anemic Patients With Low Versus Preserved Left Ventricular Ejection Fractions

Anemia is a significant co-morbidity in patients with heart failure (HF) irrespective of EF (EF) and is routinely quantified by hemoglobin concentration. Hemodilution as a cause of anemia has been described in systolic HF. This study aims to further investigate the effects of plasma volume in HF patients by 1) assessing prevalence of dilutional anemia…

Read More